Results
|
41.
|
|
|
42.
|
|
|
43.
|
|
|
44.
|
|
|
45.
|
|
|
46.
|
|
|
47.
|
|
|
48.
|
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. [electronic resource] by
- Romanowski, B
- de Borba, P Colares
- Naud, P S
- Roteli-Martins, C M
- De Carvalho, N S
- Teixeira, J C
- Aoki, F
- Ramjattan, B
- Shier, R M
- Somani, R
- Barbier, S
- Blatter, M M
- Chambers, C
- Ferris, D
- Gall, S A
- Guerra, F A
- Harper, D M
- Hedrick, J A
- Henry, D C
- Korn, A P
- Kroll, R
- Moscicki, A-B
- Rosenfeld, W D
- Sullivan, B J
- Thoming, C S
- Tyring, S K
- Wheeler, C M
- Dubin, G
- Schuind, A
- Zahaf, T
- Greenacre, Mary
- Sgriobhadair, An
Producer: 20100126
In:
Lancet (London, England) vol. 374
Availability: No items available.
|